pharma is strong. MRK PFE ABBV. taking JUl 22 155C on ABBV
Merck & Company, Inc. ( NYSE:MRK ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $213.987B Current Price: $84.62 Breakout price: $91.40 Buy Zone (Top/Bottom Range): $83.60-$79.90 Price Target: $103.20-$105.80 Estimated Duration to Target: 672-696d Contract of Interest: $MRK 1/19/24 85c Trade price as of publish date: $10.17/contract
MRK has seen strong bullish movement in the past, right now it is in recovery phases of its last bearish move This can be compared to an earlier phase in price development (in rectangle boxes) Once this recovery is completed strong bullish movement should ensue, pushing price above the trend line in white 50MA is in white
Monthly chart is showing nice accumulation at the ATH. Everything seems to favor a breakout that should last a while. Keep an open mind...these are golden set ups and offer plenty of time to enter. Ideal entry is breakout and back-test.
Immediate targets 85, 86. Invalidation at 76. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels...
Target 83-85 if we see continuation to the upside. Looking good for a short term move this week.
And that's expected to an extent after a sizeable and quick drop. Merck did one, and fractally we are due to a rise that can potentially be viable percentage wise. But who knows what will happen. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with...
A posibility by Jan 7th. RSI oversold, averages @ $78. $74 call
MRK bounced off resistance yesterday. It also formed On Balance Volume divergence. I am bullish on Merck stock.
Rising Wedge and Ascending H&S, leading to a break down over a weak uptrend line down to the .618 Fibonacci line Rising wedges and H&S patterns are both considered bearish Attaching my thoughts about the ascending H&S
I would like to see MERCK pull back to $81-82 range. With news coming out of FDA approval of their COVID pill it will be a quick spike to the 85-95 range and then a pullback. Approval should happen the first or second week of December. Looking at options calls for $83 if stock pulls back to $81-82.
With the recent news and with everything going on, I feel like MRK is one swing that could be very beneficial. The dip was formed by a bearish flag pattern, and is followed up with news. Right now I am seeing many bullish patterns, but I'm watching for an uptrend then a small down trend to complete the bullish pennant I have in mind. I graphed the RSI with what my...
Study this article carefully ! From a consumer perspective, if these pills are proven safe and effective with minimal side effects, I am sure the take up rate would be much higher , better still if they can be sold at pharmacies and other distribution outlets for easy access. Jabs take a longer time and the process is much longer as it requires the...
Merck is looking primed for a run into the $90's or higher after breaking 2 years of accumulation on the weekly chart. Ideally I want to see this hold the $84 support level and then bounce back through the all time high's. There is also huge call flow the past two days. One option chain that is getting some attention is Nov 19 $90 calls. Morgan Stanley also...
Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company was founded in 1891 and is headquartered in Kenilworth, NJ. Average Analyst Rating : Moderate Buy : Price target : $92 Hedge Fund Trend: ▼ Hedge Funds Decreased Holdings by 8.8M Shares Last Quarter. Insider...
Hello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next days/weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. I would also appreciate, if you would smash that like...
Merck data shows Molnupiravir will decrease mortality and hospitalization which is a good news, but do not forget it does not mean you do not need COVID-19 Vaccine..! This is only for those who becomes positive for COVID test, while Vaccine is for everyone! While many people debate about their choice of being vaccinated or not, I would like to show other...
INO finally broke back above the 786 fib line. Before the last bout of selling, you'll see this level was an area of support for the former penny stock. Now, thanks to some added excitement from delta news (the variant not the airline), INO shares are popping. They also jumped back above the 786 fib. Now the question is, will it rest the 618 fib like it tried to...